|
|
|
|
|
Teisinis statusas
Patentas neįsigaliojo (pagal EPK)
| (51) | INT.CL. | C07K 16/28 | |
| C07K 16/32 | |||
| A61K 38/08 | |||
| A61K 47/68 | |||
| C07K 16/30 |
| (11) | Patento numeris | 2794653 |
| (13) | Dokumento rūšis | T |
| (96) | Europos patento paraiškos numeris | 12823018.2 |
| Europos patento paraiškos padavimo data | 2012-12-19 | |
| (97) | Europos patento paraiškos paskelbimo data | 2014-10-29 |
| (45) | Paskelbimo apie Europos patento išdavimą data | 2019-03-13 |
| (46) | Apibrėžties vertimo paskelbimo data |
| (86) | Numeris | PCT/IB2012/057491 |
| Data | 2012-12-19 |
| (87) | Numeris | WO 2013/093809 |
| Data | 2013-06-27 |
| (30) | Numeris | Data | Šalis |
| 201161580169 P | 2011-12-23 | US |
| (72) |
MARQUETTE, Kimberly, US
BENNETT, Eric, US
TCHISTIAKOVA, Lioudmila, US
TUMEY, L. Nathan, US
BIKKER, Jack, US
CALABRO, Valerie, FR
GRAZIANI, Edmund, US
|
| (73) |
Pfizer Inc.,
235 East 42nd Street, New York, NY 10017,
US
|
| (54) | ENGINEERED ANTIBODY CONSTANT REGIONS FOR SITE-SPECIFIC CONJUGATION AND METHODS AND USES THEREFOR |
| ENGINEERED ANTIBODY CONSTANT REGIONS FOR SITE-SPECIFIC CONJUGATION AND METHODS AND USES THEREFOR |